OINDPnews


Aptar Pharma banner

News

Intranasal insulin shows promise for treatment of Alzheimer’s disease

According to an article published on September 12, 2011 in the Archives of Neurology, a randomized, double-blind, placebo-controlled trial has demonstrated that intranasal insulin can improve memory and the ability to perform daily functions in adults with agnestic mild cognitive impairment or Alzheimer's disease. The study is called "Study of Nasal Insulin to Fight … [Read more...] about Intranasal insulin shows promise for treatment of Alzheimer’s disease

David Harris joins Team Consulting

Team Consulting has hired David Harris, inventor of the Conix dry powder inhaler, which was licensed to 3M Drug Delivery Systems in 2008 by his then employer, Cambridge Consultants. In 2009, Harris joined Sagentia, where he was Principal Consultant. He will hold the same title at Team. "It’s fantastic to be here. I’ve known Team and some of the people who work here … [Read more...] about David Harris joins Team Consulting

Hearing in Proveris/Innova case delayed by Innova bankruptcy

Just prior to a scheduled hearing to determine sanctions in the Proveris Scientic vs. InnovaSystems case that was scheduled for September 6, 2011, InnovaSystems filed for bankruptcy, indefinitely delaying the hearing. The petition for Chapter 11 bankruptcy filed on September 2 in New Jersey lists two law firms that represented Innova in the patent infringement case as … [Read more...] about Hearing in Proveris/Innova case delayed by Innova bankruptcy

Melbourn Scientific to introduce new service at AAPS

In addition to presenting several posters related to OINDP analysis, Melbourn Scientific will also be introducing a new Qualified Person (QP) services at the upcoming American Association of Pharmaceutical Scientists (AAPS) annual meeting. The 2011 meeting will be the first AAPS annual meeting attended by Melbourn, marking the UK company's increased presence in the US … [Read more...] about Melbourn Scientific to introduce new service at AAPS

Hi-Tech Pharmacal’s fluticasone nasal spray sales more than double

First quarter sales of Hi-Tech Pharmacal's fluticasone proprionate nasal spray rose from $11,700,000 in 2010 to $26,200,000 this year, the company has announced, continuing a rapid increase in sales since the product was introduced. First quarter earnings rose 59% overall, which is mostly attributable to the increase in nasal spray sales. The fluticasone … [Read more...] about Hi-Tech Pharmacal’s fluticasone nasal spray sales more than double

Xcelience adds capacity for clinical trial supplies for DPIs

Contract drug developer Xcelience has added micro-dosing capacity for the manufacturing of clinical supplies for dry powder inhaler delivery systems. The addition of an MG Futura capsule filler, says the company, "improves upon production times, increases overall capacity, and expands upon our existing capabilities for powders, pellets and powder micro-dosing for … [Read more...] about Xcelience adds capacity for clinical trial supplies for DPIs

Iran phases out CFC inhalers

On September 5, a ceremony in Tehran marked the occasion as Iran officially phased out CFC-based metered dose inhalers (MDIs) in accordance with the Montreal Protocol, becoming the first country in the Asia-Pacific region to do so. The event, attended by government officials, clinicians, and representatives of international organizations, celebrated the closing of … [Read more...] about Iran phases out CFC inhalers